A Survival Association Study of 102 Polymorphisms Previously Associated with Survival Outcomes in Colorectal Cancer

Table 1

Clinicopathological, molecular, and treatment-related characteristics of the patients included in this study.

Variables	(%)
Sex
Female	198 (39.21)
Male	307 (60.79)
Age at diagnosis	Median: 61.43 years; (range: 20.7–75)
Histology
Nonmucinous	448 (88.71)
Mucinous	57 (11.29)
Location
Colon	334 (66.14)
Rectum	171 (33.86)
Stage
I	93 (18.42)
II	196 (38.81)
III	166 (32.87)
IV	50 (9.9)
Grade
Well/moderately differentiated	464 (91.88)
Poorly differentiated	37 (7.33)
Unknown	4 (0.79)
Vascular invasion
Absent	308 (60.99)
Present	159 (31.49)
Unknown	38 (7.52)
MSI status
MSI-L/MSS	431 (85.35)
MSI-H	53 (10.5)
Unknown	21 (4.16)